VIA Disc NP Registry 3.0

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06345690

Enrollment

500

Registered

2024-04-03

Start date

2024-02-27

Completion date

2027-01-01

Last updated

2026-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Back Pain, Back Pain, Low, Discogenic Pain

Keywords

Back Pain

Brief summary

Registry is to observe and trend patterns of care and outcomes for patients treated with VIA Disc NP.

Detailed description

The Registry is intended to collect data for patients having received treatment with VIA Disc NP.

Interventions

OTHERVIA Disc NP

VIA Disc NP - Allograft tissue injection

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

1. Willing to sign the informed consent and deemed capable of complying with the requirements of the study protocol 2. 18 years of age or older 3. Literate, able to speak and read English, and able to complete questionnaires independently 4. Subject received a VIA Disc NP injection with 1 or more levels within 90 days of the baseline visit.

Exclusion criteria

1. Participant did not receive VIA Disc NP injection 2. Participant is pregnant (self-reported, no special study pregnancy testing needed). 3. Any contraindications as noted in the VIA Disc NP Instructions for Use 4. Previous treatment with VIA Disc NP

Design outcomes

Primary

Measure	Time frame	Description
Numeric Pain Rating Scale (NPRS)	1, 3, 6, & 12 months	Change in Numeric Rating Scale (NRS) scores. Eleven point pain scale used for patient self-reporting of back pain, which ranges from 0 (no pain) to 10 (the worst pain imaginable).
Oswestry Disability Index (ODI)	1, 3, 6, & 12 months	Change in scores from Oswestry Disability Index (ODI). An index comprising of ten categories of function to quantify disability due to back pain.
Patient Satisfaction	1, 3, 6, & 12 months	Patient reported assessment of treatment regarding their experience with the procedure. Four different responses, which range from Not at all satisfied (worst) to Extremely Satisfied (best).
Frequency of Pain Medication Use	1, 3, 6, & 12 months	Assesses the frequency and type of pain medication administered to participants at baseline and follow-up visits scheduled at 1, 3, 6, and 12 months. Data will be collected to track changes in pain medication usage over time.

Countries

United States

Contacts

STUDY_DIRECTORLeslie Zaccari

Sponsor - Vivex Biologics

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 13, 2026